Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Bellerophon Ther Com (BLPH)

2.07 0 (0%)

04-18 16:00

Open:

2.07

Pre. Close:

2.07

High:

2.1

Low:

2

Volume:

95,153

Market Cap:

119M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.103 - 2.11

2.11 - 2.117

Low:

1.979 - 1.989

1.989 - 1.997

Close:

2.055 - 2.07

2.07 - 2.083

Technical analysis  (as of: 2018-04-18 4:38:34 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 2.53     One year: 2.78

Support:

Support1: 1.82    Support2: 1.51

Resistance:

Resistance1: 2.17    Resistance2: 2.38

Pivot:

2.04

Moving Averages:

MA(5): 2.07     MA(20): 2.06

MA(100): 2.12     MA(250): 1.65

MACD:

MACD(12,26): 0.02     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 43.84     %D(3): 43.50

RSI:

RSI(14): 52.78

52-Week:

High: 2.74  Low: 1  Change(%): 64.3

Average Vol(K):

3-Month: 14522  10-Days 9463

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BLPH has closed below upper band by 33.0%. Bollinger Bands are 68.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to BLPH's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-11T14:16:31-04:00
Bellerophon Therapeutics (BLPH) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

2018-03-15T16:49:24-04:00
Bellerophon Therapeutics reports Q4 results

2018-01-31T08:00:00-05:00
Your Daily Pharma Scoop: Abeona's EB-101 Granted RMAT Designation, Teva To Raise Debt, Pfizer Reports Results

2018-01-29T10:37:16-05:00
Enrollment halfway there in Bellerophon's late-stage study of INOpulse in pulmonary arterial hypertension, interim data expected mid-year

2018-01-09T12:42:09-05:00
Midday Gainers / Losers

2018-01-04T02:17:49-05:00
Your Daily Pharma Scoop: Ardelyx Reports Data, Omeros Moves Forward With OMS721, Allergan Announces Job Cuts

2018-01-03T11:05:45-05:00
Mid-stage study underway assessing Bellerophon's INOpulse in PH-ILD

2017-12-22T10:42:40-05:00
Top 2017 YTD performers - healthcare

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

57.37

Shares Float (M)

54.07

% Held by Insiders

6.00

% Held by Institutions

77.10

Shares Short (K)

2094

Shares Short Prior Month (K)

Stock Financials

EPS

-0.730

EPS Est. Current Year

-1.120

EPS Est. Next Year

-0.960

EPS Est. Next Quarter

-0.180

Forward EPS

1.#IO

Book Value (p.s.)

7.010

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-164.8

Return on Equity (ttm)

-712.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.296

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

-2.84

P/E Growth Ratio

P/BV

0.30

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.